Mark A. Exley
17Patents
6h-index
34Co-inventors
66Inventor score
Filing activity: Jun 1, 1995 → Jun 23, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5876727A | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same | Emerging Cross-Sectional Technologies | 54 | Expired |
| US6982326B1 | Allergenic proteins and peptides from Japanese cedar pollen | Human Necessities | 14 | Expired |
| US5773003A | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same | Human Necessities | 12 | Expired |
| US8138314B2 | Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations | Emerging Cross-Sectional Technologies | 10 | Active |
| US5760184A | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same | Human Necessities | 10 | Expired |
| US6090386A | T cell peptides of the CRX JII allergen | Human Necessities | 6 | Expired |
| US6054127A | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same | Human Necessities | 6 | Expired |
| US5840307A | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation | Human Necessities | 4 | Expired |
| US8084020B2 | Use of anti-CD1 antibodies for the modulation of immune responses | Emerging Cross-Sectional Technologies | 3 | Expired |
| US11718658B2 | T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US8540999B2 | Allergenic proteins and peptides from Japanese cedar pollen | Human Necessities | 0 | Active |
| US10335742B2 | Asymmetric composite membranes and modified substrates used in their preparation | Performing Operations; Transporting | 0 | Active |
| US11291215B2 | Durable asymmetric composite membranes and modified substrates used in their preparation | Emerging Cross-Sectional Technologies | 0 | Active |
| US11389771B2 | Asymmetric composite membrane and a method of preparation thereof | Performing Operations; Transporting | 0 | Active |
| US12391741B2 | T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11613764B2 | T cell receptors that bind to NY-ESO-1 and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US9907848B2 | Methods and compositions for treatment of metabolic disorders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.